Loading...
Powered By
8 items
2025-07-30
Kodama Chemical Industry Co.,Ltd. announced that they will report Q1, 2026 results on Aug 08, 2025
2025-05-15
Kodama Chemical Industry Co.,Ltd., Annual General Meeting, Jun 26, 2025.
2025-05-13
Kodama Chemical Industry Co.,Ltd. expected to report Q1 2026 results on August 8, 2025. This event was calculated by S&P Global (Created on May 13, 2025).
2025-05-02
Kodama Chemical Industry Co.,Ltd. announced that they will report fiscal year 2025 results on May 14, 2025
2025-04-02
Kodama Chemical Industry Co.,Ltd. (TSE:4222) signed memorandum of understanding to acquire Mepro Holdings Co., Ltd. from Endeavour United II Investment Business Limited Partnership, managed by Endeavour United Co., Ltd. on September 25, 2024. Kodama Chemical Industry Co.,Ltd. (TSE:4222) entered into share transfer agreement to acquire Mepro Holdings Co., Ltd. from Endeavour United II Investment Business Limited Partnership, managed by Endeavour United Co., Ltd. for ¥1 billion on February 12, 2025. For the period ended March 31, 2024 Mepro Holdings Co., Ltd. reported net loss of ¥86 million, ¥37 million. The expected completion of the transaction is April 1, 2025. As of December 6, 2024, the parties to the agreement have decided to delay the Stock transfer agreement date. Kodama Chemical Industry Co.,Ltd. (TSE:4222) completed the acquisition of Mepro Holdings Co., Ltd. from Endeavour United II Investment Business Limited Partnership, managed by Endeavour United Co., Ltd. on April 1, 2025.
2025-01-18
Kodama Chemical Industry Co.,Ltd. expected to report Fiscal Year 2025 results on May 12, 2025. This event was calculated by S&P Global (Created on January 18, 2025).
2025-01-18
Kodama Chemical Industry Co.,Ltd. announced that they will report Q3, 2025 results on Feb 12, 2025
2024-09-27
Kodama Chemical Industry Co.,Ltd. announced that they will report Q2, 2025 results on Nov 11, 2024
2025Q2 | 2025Q1 | 2024Q4 | 2024Q3 | 2024Q2 | 2024Q1 | 2023Q4 | 2023Q3 | 2023Q2 | |
|---|---|---|---|---|---|---|---|---|---|
Total Revenues | 32,072 | 15,842 | 15,348 | 15,126 | 14,821 | 14,696 | 14,848 | 15,018 | 15,317 |
Pretax Income Excl.Unusual Items | 107 | 97 | 112 | 77 | 88 | 24 | 178 | 268 | 251 |
Total Assets | 64,649 | 14,094 | 14,399 | 14,250 | 14,394 | 14,602 | 14,689 | 13,711 | 13,337 |
Total Liabilities | 36,891 | 8,625 | 9,049 | 9,020 | 9,178 | 9,364 | 9,608 | 8,692 | 8,430 |
Cash & Cash Equivalents | 11,271 | 1,618 | 1,505 | 1,586 | 1,561 | 1,799 | 1,997 | 1,396 | 1,432 |
Total Common Equity | 26,153 | 4,058 | 4,028 | 3,937 | 3,961 | 4,041 | 3,894 | 3,878 | 3,802 |
Book Value Per Share (BVPS) | 1,674.32 | 259.94 | 516.73 | 505.05 | 508.13 | 518.38 | 499.52 | 497.87 | 488.1 |
Net Change in Cash | -548 | -149 | 212 | -113 | |||||
Capital Expenditure | -849 | -1,382 | -1,805 | -1,318 |
As of August 08, 2025, Kodama Chemical Industry published financial results for the second quarter of 2025, with revenues of 20.09B yen and net income of 22.38B yen, indicating a significant 420.8% surge in revenues, with a transition from a loss per share in the same quarter last year to a profit per share in the current quarter. A positive sign is that for the 5th consecutive quarter, the company has demonstrated an increase in its income line compared to the corresponding quarter of the previous year, indicating the company's stability and potential for growth in the future.
In addition, the EBITDA margin droped sharply from 4.9% in the corresponding quarter last year to 3.6%. A decrease in operating profitability may indicate a difficulty in sales or an increase in operating expenses, potentially harming the stock's future performance. and it trades at 0.4x times current year's earnings, which is lower than the sector average (P/E 13.4x).